Calif. Dx firm raises funds for prostate cancer test

10/1/2013 | GenomeWeb Daily News (free registration)

GenomeDx Biosciences has secured an undisclosed amount in a Series B round of financing led by Merck Global Health Innovation Fund. The San Diego company will use the funding to support commercial growth of its Decipher test, designed to predict a patient's risk of developing prostate cancer.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC